AAAAAA

   
Results: 1-20 |
Results: 20
Robust prostate-specific expression for targeted gene therapy based on thehuman kallikrein 2 promoter
Authors: Xie, XM Zhao, XQ Liu, YF Young, CYF Tindall, DJ Slawin, KM Spencer, DM
Citation: Xm. Xie et al., Robust prostate-specific expression for targeted gene therapy based on thehuman kallikrein 2 promoter, HUM GENE TH, 12(5), 2001, pp. 549-561
Prediction of response to salvage radiation therapy in patients with prostrate cancer recurrence after radical prostatectomy
Authors: Leventis, AK Shariat, SF Kattan, MW Butler, EB Wheeler, TM Slawin, KM
Citation: Ak. Leventis et al., Prediction of response to salvage radiation therapy in patients with prostrate cancer recurrence after radical prostatectomy, J CL ONCOL, 19(4), 2001, pp. 1030-1039
Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy
Authors: Shariat, SF Shalev, M Menesses-Diaz, A Kim, IY Kattan, MW Wheeler, TM Slawin, KM
Citation: Sf. Shariat et al., Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy, J CL ONCOL, 19(11), 2001, pp. 2856-2864
Characteristics of normal prostate vascular anatomy as displayed by power Doppler
Authors: Leventis, AK Shariat, SF Utsunomiya, T Slawin, KM
Citation: Ak. Leventis et al., Characteristics of normal prostate vascular anatomy as displayed by power Doppler, PROSTATE, 46(4), 2001, pp. 281-288
Local recurrence after radical prostatectomy: Correlation of US features with prostatic fossa biopsy findings
Authors: Leventis, AK Shariat, SF Slawin, KM
Citation: Ak. Leventis et al., Local recurrence after radical prostatectomy: Correlation of US features with prostatic fossa biopsy findings, RADIOLOGY, 219(2), 2001, pp. 432-439
Bilateral nerve graft during radical retropubic prostatectomy: 1-year followup
Authors: Kim, ED Nath, R Kadmon, D Lipshultz, LI Miles, BJ Slawin, KM Tang, HY Wheeler, T Scardino, PT
Citation: Ed. Kim et al., Bilateral nerve graft during radical retropubic prostatectomy: 1-year followup, J UROL, 165(6), 2001, pp. 1950-1956
Optimal combinations of systematic sextant and laterally directed biopsiesfor detection of prostate cancer
Authors: Gore, JL Shariat, SF Miles, BJ Kadmon, D Jiang, N Wheeler, TM Slawin, KM
Citation: Jl. Gore et al., Optimal combinations of systematic sextant and laterally directed biopsiesfor detection of prostate cancer, J UROL, 165(5), 2001, pp. 1554-1559
Adenovirus-mediated transfer of inducible caspases: A novel "death switch"gene therapeutic approach to prostate cancer
Authors: Shariat, SF Desai, S Song, WT Khan, T Zhao, J Nguyen, C Foster, BA Greenberg, N Spencer, DM Slawin, KM
Citation: Sf. Shariat et al., Adenovirus-mediated transfer of inducible caspases: A novel "death switch"gene therapeutic approach to prostate cancer, CANCER RES, 61(6), 2001, pp. 2562-2571
Adenovirus-mediated tissue-targeted expression of a Caspase-9-based artificial death switch for the treatment of prostate cancer
Authors: Xie, XM Zhao, XQ Liu, YF Zhang, JF Matusik, RJ Slawin, KM Spencer, DM
Citation: Xm. Xie et al., Adenovirus-mediated tissue-targeted expression of a Caspase-9-based artificial death switch for the treatment of prostate cancer, CANCER RES, 61(18), 2001, pp. 6795-6804
Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy (vol 18, pg 1039, 2001)
Authors: Leventis, AK Shariat, SF Kattan, MW Butler, EB Wheeler, TM Slawin, KM
Citation: Ak. Leventis et al., Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy (vol 18, pg 1039, 2001), J CL ONCOL, 19(7), 2000, pp. 2109-2109
Diagnosis and management of incidental ureterocele during the treatment ofclinically localized prostate cancer
Authors: Leventis, AK Miles, BJ Gonzales, ET Slawin, KM
Citation: Ak. Leventis et al., Diagnosis and management of incidental ureterocele during the treatment ofclinically localized prostate cancer, WORLD J URO, 18(6), 2000, pp. 444-448
Seminal plasma contains "BPSA," a molecular form of prostate-specific antigen that is associated with benign prostatic hyperplasia
Authors: Mikolajczyk, SD Millar, LS Marker, KM Wang, TJ Rittenhouse, HG Marks, LS Slawin, KM
Citation: Sd. Mikolajczyk et al., Seminal plasma contains "BPSA," a molecular form of prostate-specific antigen that is associated with benign prostatic hyperplasia, PROSTATE, 45(3), 2000, pp. 271-276
Correlation of preoperative plasma IGF-I levels with pathologic parametersand progression in patients undergoing radical prostatectomy
Authors: Shariat, SF Bergamaschi, F Adler, HL Nguyen, C Kattan, MW Wheeler, TM Slawin, KM
Citation: Sf. Shariat et al., Correlation of preoperative plasma IGF-I levels with pathologic parametersand progression in patients undergoing radical prostatectomy, UROLOGY, 56(3), 2000, pp. 423-429
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging
Authors: Catalona, WJ Southwick, PC Slawin, KM Partin, AW Brawer, MK Flanigan, RC Patel, A Richie, JP Walsh, PC Scardino, PT Lange, PH Gasior, GH Loveland, KG Bray, KR
Citation: Wj. Catalona et al., Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging, UROLOGY, 56(2), 2000, pp. 255-260
Percentage of free PSA in black versus white men for detection and stagingof prostate cancer: A prospective multicenter clinical trial
Authors: Catalona, WJ Partin, AW Slawin, KM Naughton, CK Brawer, MK Flanigan, RC Richie, JP Patel, A Walsh, PC Scardino, PT Lange, PH deKernion, JB Southwick, PC Loveland, KG Parson, RE Gasior, GH
Citation: Wj. Catalona et al., Percentage of free PSA in black versus white men for detection and stagingof prostate cancer: A prospective multicenter clinical trial, UROLOGY, 55(3), 2000, pp. 372-376
"BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia
Authors: Mikolajczyk, SD Millar, LS Wang, TJ Rittenhouse, HG Wolfert, RL Marks, LS Song, WT Wheeler, TM Slawin, KM
Citation: Sd. Mikolajczyk et al., "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia, UROLOGY, 55(1), 2000, pp. 41-45
Benign prostatic hyperplasia-associated prostate-specific antigen (BPSA) shows unique immunoreactivity with anti-PSA monoclonal antibodies
Authors: Wang, TJ Slawin, KM Rittenhouse, HG Millar, LS Mikolajczyk, SD
Citation: Tj. Wang et al., Benign prostatic hyperplasia-associated prostate-specific antigen (BPSA) shows unique immunoreactivity with anti-PSA monoclonal antibodies, EUR J BIOCH, 267(13), 2000, pp. 4040-4045
A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue
Authors: Mikolajczyk, SD Millar, LS Wang, TJ Rittenhouse, HG Marks, LS Song, WT Wheeler, TM Slawin, KM
Citation: Sd. Mikolajczyk et al., A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue, CANCER RES, 60(3), 2000, pp. 756-759
Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein
Authors: Slawin, KM Shariat, SF Nguyen, C Leventis, AK Song, WT Kattan, HW Young, CYF Tindall, DJ Wheeler, TM
Citation: Km. Slawin et al., Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein, CANCER RES, 60(24), 2000, pp. 7142-7148
Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: A prospective multicenter clinical trial
Authors: Southwick, PC Catalona, WJ Partin, AW Slawin, KM Brawer, MK Flanigan, RC Patel, A Richie, JP Walsh, PC Scardino, PT Lange, PH Gasior, GH Parson, RE Loveland, KG
Citation: Pc. Southwick et al., Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: A prospective multicenter clinical trial, J UROL, 162(4), 1999, pp. 1346-1351
Risultati: 1-20 |